CN Stock MarketDetailed Quotes
002173 Innovative Medical Management
- 8.09
- -0.55-6.37%
Market Closed Nov 22 15:00 CST
3.57BMarket Cap-74220P/E (TTM)
8.56High8.05Low349.34KlotVolume8.56Open8.64Pre Close291.91MTurnover8.40%Turnover RatioLossP/E (Static)441.28MShares11.2052wk High1.94P/B3.36BFloat Cap5.8052wk Low9.50Limit Up415.69MShs Float31.23Historical High7.78Limit Down5.90%Amplitude2.57Historical Low--Dividend TTM8.36Avg Price202.86KlotAsk--Div YieldTTM100Lot Size139.11KlotBid
Innovative Medical Management Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -0.63%597.55M | -7.68%381.99M | -16.89%179.4M | 9.55%753.77M | 26.96%601.35M | 55.97%413.79M | 65.98%215.86M | -5.28%688.08M | -13.00%473.64M | -20.77%265.31M |
| Refunds of taxes and levies | 604.79%1.05M | 604.79%1.05M | --1.87K | -91.10%149.34K | -91.10%149.34K | -91.10%149.34K | ---- | --1.68M | 12,610.62%1.68M | --1.68M |
| Cash received relating to other operating activities | -28.98%12.13M | -14.96%9.69M | -45.08%3.51M | -17.48%23.1M | -24.12%17.08M | 21.05%11.4M | 62.60%6.38M | -12.18%27.99M | -22.29%22.51M | -53.02%9.41M |
| Cash inflows from operating activities | -1.27%610.73M | -7.66%392.73M | -17.70%182.9M | 8.26%777.02M | 24.26%618.58M | 53.88%425.33M | 65.88%222.24M | -5.35%717.74M | -13.18%497.83M | -22.12%276.4M |
| Goods services cash paid | 0.62%265.74M | -7.59%165.57M | -17.72%83.02M | 21.65%327.63M | 44.32%264.1M | 76.62%179.17M | 42.52%100.89M | 0.94%269.33M | -11.53%183M | -26.43%101.44M |
| Staff behalf paid | 2.84%263.62M | 3.64%180.4M | 4.70%97.55M | 0.20%336.28M | -3.14%256.34M | 1.10%174.07M | 1.17%93.17M | -5.15%335.61M | -1.70%264.64M | -5.87%172.17M |
| All taxes paid | 44.36%12.03M | 59.43%10.41M | 89.08%8.45M | 30.57%12.34M | 6.34%8.33M | 9.18%6.53M | 109.63%4.47M | -42.19%9.45M | -41.01%7.83M | -39.10%5.98M |
| Cash paid relating to other operating activities | -12.37%53.71M | -18.78%39.73M | 1.87%11.55M | -29.78%89.74M | -45.87%61.29M | -40.66%48.91M | -72.81%11.34M | 64.02%127.8M | 206.97%113.23M | 281.02%82.42M |
| Cash outflows from operating activities | 0.85%595.09M | -3.07%396.11M | -4.43%200.57M | 3.21%765.99M | 3.76%590.06M | 12.89%408.67M | 1.52%209.87M | 3.82%742.19M | 8.07%568.7M | 2.78%362.02M |
| Net cash flows from operating activities | -45.16%15.64M | -120.27%-3.38M | -242.76%-17.66M | 145.12%11.03M | 140.24%28.52M | 119.46%16.66M | 117.01%12.37M | -156.36%-24.45M | -250.23%-70.87M | -3,315.37%-85.62M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --412.84M | --312.61M | --304.56M | ---- | ---- | ---- | ---- | -15.00%595M | -19.29%565M | -19.29%565M |
| Cash received from returns on investments | ---- | ---- | --395.89K | ---- | ---- | ---- | ---- | 68.70%17.73M | 30.46%13.76M | 30.46%13.76M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -16.01%348.53K | -78.21%74.51K | ---- | 18.01%343.63K | 59.00%414.98K | 31.04%342.01K | --215K | 98.25%291.19K | 160.33%261K | 170.61%261K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.94%767.02K | -98.39%600K | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | --551.85K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 99,469.13%413.19M | 91,327.52%312.69M | 141,741.48%304.96M | -99.85%895.48K | -99.93%414.98K | -99.94%342.01K | -99.62%215K | -18.70%613.79M | -23.23%579.62M | -23.31%579.02M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -15.02%56.94M | -24.81%33.15M | -26.97%16.42M | -21.87%96.24M | -28.81%67M | -33.80%44.09M | -37.12%22.48M | 11.25%123.18M | 28.25%94.12M | 8.06%66.6M |
| Cash paid to acquire investments | --461.86M | --344.28M | --397.9K | 966.66%320M | ---- | ---- | ---- | -95.68%30M | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -64.19%600K | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --22.56K | ---- |
| Cash outflows from investing activities | 674.28%518.8M | 756.09%377.43M | -25.20%16.82M | 170.67%416.24M | -28.83%67M | -33.80%44.09M | -65.81%22.48M | -80.95%153.78M | -87.77%94.14M | -90.53%66.6M |
| Net cash flows from investing activities | -58.60%-105.61M | -48.00%-64.74M | 1,394.08%288.14M | -190.29%-415.34M | -113.72%-66.59M | -108.54%-43.75M | -126.52%-22.27M | 978.12%460.01M | 3,323.45%485.48M | 891.25%512.42M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | --404.65K | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 63.33%49M | --21M | --13M | 30.43%30M | 200.00%30M | ---- | ---- | 666.67%23M | --10M | --10M |
| Cash received relating to other financing activities | --2.14M | --2.14M | --1.83M | --1.16M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 68.19%51.14M | --23.14M | --14.83M | 35.48%31.16M | 204.05%30.4M | ---- | ---- | 666.67%23M | 1,080.63%10M | 1,084.27%10M |
| Borrowing repayment | 30.43%30M | ---- | ---- | 91.67%23M | 155.56%23M | 155.56%23M | -66.67%3M | -63.64%12M | -42.31%9M | 1,400.00%9M |
| Dividend interest payment | 60.20%1.84M | 33.99%1.11M | 48.67%599.83K | 83.90%1.46M | 71.30%1.15M | 124.68%831.06K | 101.67%403.47K | -66.24%794.98K | -67.76%671.05K | -73.24%369.88K |
| Cash payments relating to other financing activities | 101.64%11.3M | 63.09%6.94M | 42.04%3.78M | -11.41%11.67M | -21.54%5.6M | 27.81%4.25M | 73.60%2.66M | -83.33%13.18M | -89.69%7.14M | -95.03%3.33M |
| Cash outflows from financing activities | 45.00%43.14M | -71.33%8.05M | -27.77%4.38M | 39.13%36.14M | 76.96%29.75M | 121.17%28.08M | -43.49%6.07M | -77.30%25.97M | -80.67%16.81M | -81.58%12.7M |
| Net cash flows from financing activities | 1,128.63%8M | 153.72%15.09M | 272.34%10.45M | -67.40%-4.98M | 109.55%650.83K | -940.89%-28.08M | 43.49%-6.07M | 97.33%-2.97M | 92.09%-6.81M | 96.04%-2.7M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -119.06%-81.97M | 3.87%-53.03M | 1,860.36%280.93M | -194.61%-409.29M | -109.18%-37.42M | -113.01%-55.17M | 82.90%-15.96M | 459.21%432.59M | 854.75%407.79M | 3,187.70%424.11M |
| Add:Begin period cash and cash equivalents | -62.17%249.02M | -62.17%249.02M | -62.17%249.02M | 191.66%658.31M | 191.66%658.31M | 191.66%658.31M | 191.67%658.34M | -34.79%225.71M | -34.79%225.71M | -34.79%225.71M |
| End period cash equivalent | -73.10%167.05M | -67.51%195.99M | -17.50%529.95M | -62.17%249.02M | -1.99%620.88M | -7.18%603.14M | 385.16%642.38M | 191.66%658.31M | 116.87%633.5M | 95.49%649.82M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data